UnitedHealth Gains On Strong 4Q Results, 2019 Looks Favorable
Zacks Investment Research | Jan 16, 2019 02:14AM ET
Shares of UnitedHealth Group Inc. (NYSE:UNH) gained following strong fourth-quarter and full-year 2018 earnings, which beat estimates and grew year over year. A confident outlook for 2019 was another driving factor behind the rise in the stock.
The stock gained almost 3.6% on the day following strong fourth-quarter results.
In a year's time the stock has gained 11.8% compared with the industry 's growth of 10%.
Management sounded confident about its business fundamentals in 2019, reflecting its ability to invest, innovate and grow and in the breadth of opportunities across health care.
The company maintained its tradition of beating its own guidance with fourth-quarter and full-year 2018 adjusted earnings per share coming in above the guidance provided at the company’s investor conference.
UnitedHealth’s full-year 2018 revenues exceeded $226 billion, growing 12% year over year, while adjusted earnings per share grew 28% to $12.88 per share.
Most impressive was the company’s earnings from its Optum segment, which is the health service part of the company. It provides revenues which are outside the purview of the numerous regulations that bind its health insurance business provided by the segment UnitedHealthcare. Most noteworthy, full-year 2018 Optum revenues surpassed $100 billion for the first time.
Its major segment, UnitedHealthcare grew to serve 2.4 million more people with revenues up 12% year over year to $183.5 billion. UnitedHealthcare earnings from operations were $9.1 billion, consistent with the outlook provided by the company in November.
The segment’s performance was weighed down slightly by pressures in a handful of Medicaid markets in the fourth quarter. However, actions executed on both structural costs and rate recovery, will ensure return to stronger margin levels for this business in 2019.
Strategic investments made over the past 20 years, with strong business wins and pipelines and the many platform expansion opportunities in the United States along with global expansion positions the company for strong growth in the coming years.
UnitedHealth, with a Zacks Rank #2 (Buy), has got this reporting cycle off to a flying start. While the other players in the health care space are lined up to report financial results, below are three stocks, poised to beat on earnings per the proven Zacks model. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Get The News You Want
HCA Healthcare, Inc. (NYSE:HCA) has an Earnings ESP of +2.09% and a Zacks Rank #1 (Strong Buy). The company is expected to report fourth-quarter earnings results on Jan 29.
Humana Inc. (NYSE:HUM) has an Earnings ESP of +0.22% and a Zacks Rank #2. The company is expected to report fourth-quarter earnings results on Feb 6.
Tenet Healthcare Corp. (NYSE:THC) has an Earnings ESP of +16.7% and a Zacks Rank #3. The company is expected to report fourth-quarter earnings results on Feb 25.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.